Towards a vaccine to prevent cancer in Lynch syndrome patients

Familial Cancer

Volumn 12, Issue 2, 2013, Pages 307-312

  Von Knebel Doeberitz, Magnus ^a   Kloor, Matthias ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Colorectal cancer; Frameshift peptides; Immune therapy; Lynch syndrome; Microsatellite instability

Indexed keywords

ANTIGEN; CANCER VACCINE; FRAMESHIFT PEPTIDE ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER PREVENTION; DRUG TARGETING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOPHENOTYPING; MICROSATELLITE INSTABILITY; PATHOGENESIS; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; CANCER VACCINES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FRAMESHIFT MUTATION; HUMANS;

EID: 84880920149     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-013-9662-7     Document Type: Article

References (51)

1. Watson P, Lin KM, Rodriguez-Bigas MA et al (1998) Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer 83:259-266
2. Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23:609-618
3. Kim H, Jen J, Vogelstein B, Hamilton SR (1994) Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 145:148-156
4. Risio M, Reato G, di Celle PF et al (1996) Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer. Cancer Res 56:5470-5474
5. Dolcetti R, Viel A, Doglioni C et al (1999) High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 154:1805-1813
6. Michael-Robinson JM, Biemer-Hüttmann A et al (2001) Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut 48:360-366
7. Shia J, Ellis NA, Paty PB et al (2003) Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 27:1407-1417
8. Smyrk TC, Watson P, Kaul K et al (2001) Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 91:2417-2422
9. Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960-1964
10. Phillips SM, Banerjea A, Feakins R et al (2004) Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surg 91:469-475
11. Michel S, Benner A, Tariverdian M et al (2008) High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. Br J Cancer 99:1867-1873
12. Bauer K, Michel S, Reuschenbach M et al (2011) Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer. Fam Cancer 10:557-565
13. Banerjea A, Ahmed S, Hands RE et al (2004) Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity. Mol Cancer 3:21
14. Bernal M, García-Alcalde F, Concha A et al (2012) Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape. Cancer Immunol Immunother 61:803-816
15. de Miranda NF, Goudkade D, Jordanova ES et al (2012) Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases. Clin Cancer Res 18:1237-1245
16. Jiricny J (2006) The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 7:335-346
17. Duval A, Hamelin R (2002) Genetic instability in human mismatch repair deficient cancers. Ann Genet 45:71-75
18. Markowitz S, Wang J, Myeroff L et al (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338
19. Ionov Y, Yamamoto H, Krajewski S et al (2000) Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci U S A 97:10872-10877
20. Markowitz SD, Roberts AB (1996) Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev 7:93-102
21. Woerner SM, Kloor M, von Knebel Doeberitz M et al (2006) Microsatellite instability in the development of DNA mismatch repair deficient tumors. Cancer Biomark 2:69-86
22. Townsend A, Ohlen C, Rogers M et al (1994) Source of unique tumour antigens. Nature 371:662
23. Saeterdal I, Bjorheim J, Lislerud K et al (2001) Frameshift-mutation- derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci U S A 98:13255-13260
24. Linnebacher M, Gebert J, Rudy W et al (2001) Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens. Int J Cancer 93:6-11
25. Ripberger E, Linnebacher M, Schwitalle Y et al (2003) Identification of an HLA-A0201-restricted CTL epitope generated by a tumor-specific frameshift mutation in a coding microsatellite of the OGT gene. J Clin Immunol 23:415-423
26. Schwitalle Y, Linnebacher M, Ripberger E et al (2004) Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells. Cancer Immun 4:14
27. Garbe Y, Maletzki C, Linnebacher M (2011) An MSI tumor specific frameshift mutation in a coding microsatellite of MSH3 encodes for HLA-A0201-restricted CD8+ cytotoxic T cell epitopes. PLoS ONE 6:e26517
28. Schwitalle Y, Kloor M, Eiermann S et al (2008) Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134:988-997
29. Bauer K, Nelius N, Reuschenbach M et al (2012) T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer. Cancer Immunol Immunother 62:27-37
30. Ribic CM, Sargent DJ, Moore MJ et al (2003) Tumor microsatellite- instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349:247-257
31. Sargent DJ, Marsoni S, Monges G et al (2010) Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 28:3219-3226
32. Sinicrope FA, Foster NR, Thibodeau SN et al (2011) DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst 103:863-875
33. Burn J, Gerdes AM, Macrae F et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378:2081-2087
34. Czéh M, Loddenkemper C, Shalapour S et al (2010) The immune response to sporadic colorectal cancer in a novel mouse model. Oncogene 29:6591-6602
35. Reuschenbach M, Kloor M, Morak M et al (2010) Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome. Fam Cancer 9:173-179
36. Marsh L, Coletta PL, Hull MA et al (2012) Altered intestinal epithelium-associated lymphocyte repertoires and function in ApcMin/+mice. Int J Oncol 40:243-250
37. Bicknell DC, Kaklamanis L, Hampson R et al (1996) Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr Biol 6:1695-1697
38. Kloor M, Becker C, Benner A et al (2005) Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. Cancer Res 65:6418-6424
39. Kloor M, Michel S, Buckowitz B et al (2007) Beta2-microglobulin mutations in microsatellite unstable colorectal tumors. Int J Cancer 121:454-458
40. Dierssen JW, de Miranda NF, Ferrone S et al (2007) HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression. BMC Cancer 7:33
41. Chang CC, Ferrone S (2007) Immune selective pressure and HLA class I antigen defects in malignant lesions. Cancer Immunol Immunother 56:227-236
42. Koelzer VH, Baker K, Kassahn D et al (2012) Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status. J Clin Pathol 65:996-1002
43. Tikidzhieva A, Benner A, Michel S et al (2012) Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial. Br J Cancer 106:1239-1245
44. Huang WC, Wu D, Xie Z et al (2006) Beta2-Microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res 66:9108-9116
45. Josson S, Nomura T, Lin JT et al (2011) b2-Microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Res 71:2600-2610
46. Ma D, Luyten GP, Luyder TM et al (1995) Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci 36:435-441
47. Jager MJ, Hurks HM, Levitskaya J et al (2002) HLA expression in uveal melanoma: there is no rule without some exception. Hum Immunol 63:444-451
48. Bernal M, Ruiz-Cabello F, Concha A et al (2012) Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes. Cancer Immunol Immunother 61:1359-1371
49. Michel S, Linnebacher M, Alcaniz J et al (2010) Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes. Int J Cancer 127:889-898
50. Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol 6:479-507
51. Kloor M, Huth C, Voigt AY et al (2012) Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study. Lancet Oncol 13:598-606